Concepedia

Author

Joachim Diessner

University of Würzburg

Also Known As

Diessner, Joachim E, J Diessner, J. Diessner, Joachim Diessner, Joachim E. Diessner

43

Publications

653

Citations

12

H-Index

22

Concepts

All Affiliations

University of WürzburgUniversity of BremenInstitut für Medizinische Biometrie, Informatik und EpidemiologieJohannes Gutenberg University MainzUniversitätsklinikum Würzburg
JD

About

Joachim Diessner is an author at University of Würzburg specializing in medicine, tumor immunity, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

155

2

Cell Biology

2

2

133

3

Nursing

1

1

22

4

Cellular Therapies

1

1

21

5

Health Policy

1

1

22

Joachim Diessner

×

12

Publications

576

Citations

12

H-Index

YearCitations

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape

I Montalban del Barrio, Cornelia Penski, Laura Schlahsa,

Journal for ImmunoTherapy of Cancer

2016

150

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion.

Sebastian Häusler, I Montalban del Barrio, Joachim Diessner,

PubMed

2014

112

Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

Markus Haake, Beatrice Haack, Tina Schäfer,

Nature Communications

2023

88

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer

Joachim Diessner, Manfred Wischnewsky, Tanja Stüber,

BMC Cancer

2016

56

Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell–like Properties

Roland Stein, Stefan Ebert, Laura Schlahsa,

Cancer Research

2019

43

Effect of adjuvant radiotherapy in elderly patients with breast cancer

Tanja Nadine Stueber, Joachim Diessner, Catharina Bartmann,

PLoS ONE

2020

23

Guidelines are advantageous, though not essential for improved survival among breast cancer patients

Regine Wolters, Jörg Wischhusen, Tanja Stüber,

Breast Cancer Research and Treatment

2015

22

Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells.

Joachim Diessner, Valentin Bruttel, Kathrin Becker,

PubMed

2013

21

The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic

Theresa Hübner, Tanja Wolfgang, Ann-Catrin Theis,

Reproductive Health

2022

19

Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study

Joachim Diessner, Manfred Wischnewsky, Maria Blettner,

PLoS ONE

2016

18

Page 1